Friday, March 29, 2024

IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening

IQVIA™ , a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today with (RED), the organization co-founded by Bono and Bobby Shriver to fight AIDS and the injustices that enable pandemics to thrive, to support laboratory system strengthening and save lives.

The $5 million impact partnership will channel life-saving money to the Global Fund’s Laboratory Systems Integration Fund. Doubling the impact, the Bill & Melinda Gates Foundation will match every dollar from the partnership to the Global Fund.

“We can’t end the AIDS pandemic and prevent future pandemics without the life science industry. (RED) is delighted to add IQVIA to our dedicated family of life-science partners who are helping make preventable and treatable disease preventable and treatable for everyone.”

“Every day, IQVIA works alongside our customers and partners to help improve global health. This impact partnership is the latest example of IQVIA’s commitment to improving healthcare systems in low- and middle-income countries, to ultimately drive healthcare forward and create a healthier world,” said David Franks, Vice President, Global Public Health, IQVIA.

Also Read: Caster Concepts unveils line of spring-loaded aluminum casters ideal for the automotive, ground support and aerospace assembly

“Partnerships like the one we are announcing today with IQVIA are key to building more resilient and responsive laboratories and global health systems,” said Jennifer Lotito, President and COO of (RED). “We can’t end the AIDS pandemic and prevent future pandemics without the life science industry. (RED) is delighted to add IQVIA to our dedicated family of life-science partners who are helping make preventable and treatable disease preventable and treatable for everyone.”

“If there’s one thing that we have learned even more clearly from COVID-19, it is that rapid diagnosis is the first line of defense against any infectious disease outbreak,” said Peter Sands, the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “At a time when global health leaders are working toward a pandemic treaty, this new Integration Fund demonstrates the will to fight today’s infectious diseases and prepare for tomorrow’s pandemics.”

The Global Fund’s Laboratory Systems Integration Fund aims to advance laboratory systems readiness and capability ratings in over a dozen low- and middle-income countries across Africa, Asia and Latin America to detect and respond to potential local health threats before they become global pandemics. Along with IQVIA, the Fund is backed by $54 million in investments from The Rockefeller Foundation, The Abbott Fund, the philanthropic foundation of the global healthcare company Abbott, and the Global Fund, along with 10 other recipient countries.

SOURCE: Businesswire 

Subscribe Now

    Hot Topics